LGND Ligand Pharmaceuticals Incorporated

USD 110.22 +0.18 ( +0.16)%
Icon

Ligand Pharmaceuticals Incorporated (LGND) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 110.22

+0.18 (+0.16)%

USD 2.11B

0.10M

USD 132.14(+19.89%)

USD 200.00 (+81.46%)

Icon

LGND

Ligand Pharmaceuticals Incorporated (USD)
COMMON STOCK | NSD
USD 110.22
+0.18 ( +0.16)%

Ligand Pharmaceuticals Incorporated (LGND) Stock Forecast

Show ratings and price targets of :
USD 132.14
(+19.89%)

Based on the Ligand Pharmaceuticals Incorporated stock forecast from 4 analysts, the average analyst target price for Ligand Pharmaceuticals Incorporated is USD 132.14 over the next 12 months. Ligand Pharmaceuticals Incorporated’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Ligand Pharmaceuticals Incorporated is Neutral, which is based on 7 positive signals and 6 negative signals. At the last closing, Ligand Pharmaceuticals Incorporated’s stock price was USD 110.22. Ligand Pharmaceuticals Incorporated’s stock price has changed by -2.79% over the past week, +5.19% over the past month and +1,124.89% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...